Last 73.00 GBp
Change Today +4.50 / 6.57%
Volume 85.5K
TSTL On Other Exchanges
As of 11:30 AM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

tristel plc (TSTL) Snapshot

68.50 GBp
Previous Close
68.50 GBp
Day High
73.00 GBp
Day Low
68.50 GBp
52 Week High
07/3/14 - 89.50 GBp
52 Week Low
10/3/13 - 23.50 GBp
Market Cap
Average Volume 10 Days
0.03 GBp
Shares Outstanding
0.76 GBp
Dividend Yield
Current Stock Chart for TRISTEL PLC (TSTL)

Related News

No related news articles were found.

tristel plc (TSTL) Related Businessweek News

No Related Businessweek News Found

tristel plc (TSTL) Details

Tristel plc designs, manufactures, and sells infection control, contamination control, and hygiene products in the United Kingdom and internationally. It offers human health care disinfectant products under the Tristel brand for use in the disinfection of specialist instruments, hospital surfaces, and water supplies. The company provides wipes systems for use in ear, nose, throat, cardiology, neonatal incubators, ophthalmology, and ultrasound departments; and liquid disinfectants to disinfect instruments in urology, dentistry, endoscopy, laboratories/pathology, reproductive health/IVF, and respiratory medicine, as well as decontamination systems for urology, respiratory medicine, and gynecology. Its products also include surface disinfectant products in the forms of liquids, gels, foams, and wipes to clean and disinfect hospital surfaces, such as ward floors, operating theatre walls, bed mattresses, commodes, and patient trolleys; and water disinfection products to control bacterium found in drinking water and cooling towers. In addition, the company offers animal healthcare disinfectants and cleaning products comprising airborne disinfectants, surface disinfectants, instrument cleaners, instrument disinfectants, hand hygiene and skin care products, and odor eliminators under the Anistel, Dermastel, Enzystel, Medistel, Airstel, and Odostel brands for infection prevention and hygiene in veterinary practices and animal welfare establishments. Further, it provides detergents and disinfectants, including sterile products for use in the clean rooms of pharmaceutical manufacturers and the aseptic units of hospitals to prevent the microbial contamination of the critical environments in which drugs are produced; and non-sterile products for use in the production facilities of manufacturers of personal care products to prevent cross-contamination between batch manufacturing processes. Tristel plc was founded in 1993 and is based in Snailwell, the United Kingdom.

92 Employees
Last Reported Date: 10/15/13
Founded in 1993

tristel plc (TSTL) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: 143.0K GBP
Finance Director and Director
Total Annual Compensation: 90.0K GBP
Compensation as of Fiscal Year 2013.

tristel plc (TSTL) Key Developments

Tristel Plc Reports Earnings Results for the Second Half and Full Year of 2014

Tristel Plc reported earnings results for the second half and full year of 2014. For the second half, the company reported revenue of GBP 7.04 million against GBP 6.44 million in first half of 2014. For the year, the company reported revenues of GBP 13.48 million up 27.7% on previous year GBP 10.56 million a year ago. Pre-tax profit was GBP 1.8 million before share based payments against GBP 0.48 million a year ago. Net cash of GBP 2.59 million at 30 June, 2014 against GBP 0.49 million a year ago.

Tristel Plc Provides Earnings Guidance for the Year Ending June 30, 2014

Tristel Plc provided earnings guidance for the year ending June 30, 2014. The company anticipates further acceleration in revenue growth and as a consequence has raised its internal expectations both for the current and subsequent financial years. Pre-tax profit (before share-based payments) for the year ending June 30, 2014 is now expected to be not less than £1.75 million.

Tristel Plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2013; Declares Interim Dividend, Payable on April 14, 2014; Proposes Interim Dividend for the Year Ending June 30, 2014

Tristel Plc reported unaudited consolidated earnings results for the six months ended December 31, 2013. For the period, the company reported revenue of £6.44 million compared to £4.40 million a year ago. Operating profit was £723,000 compared to operating loss of £2.66 million a year ago. Profit before taxation was £724,000 compared to loss before taxation of £2.67 million a year ago. Profit for the period attributable to equity holders of the parent was £413,000 or 1.03 pence per basic and diluted share compared to loss for the period attributable to equity holders of the parent of £1.85 million or 4.73 pence per basic and diluted share a year ago. Cash flows generated from operating activities was £1.60 million compared to cash flows used in operating activities of £450,000 a year ago. Purchase of intangible assets was £197,000 compared to £189,000 a year ago. Purchase of property, plant and equipment was £285,000 compared to £100,000 a year ago. As a statement of confidence in the Group's future prospects, the company is declaring an interim dividend of 0.36 pence compared to 0.08 pence in 2012, payable on April 14, 2014 to shareholders on the register at March 28, 2014. The corresponding ex-dividend date is March 26, 2014. The company also proposed interim dividend for the year ending June 30, 2014 of 0.36 pence compared to 0.27 pence in 2013 per share.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TSTL:LN 73.00 GBp +4.50

TSTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TSTL.
View Industry Companies

Industry Analysis


Industry Average

Valuation TSTL Industry Range
Price/Earnings 26.8x
Price/Sales 2.1x
Price/Book 2.4x
Price/Cash Flow 14.3x
TEV/Sales 2.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRISTEL PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at